Bioptik Technology Incorporation reported earnings results for the third quarter and nine months ended September 30, 2022. For the third quarter, the company reported sales was TWD 227.23 million compared to TWD 199.16 million a year ago. Net income was TWD 28.93 million compared to TWD 11.17 million a year ago. Basic earnings per share from continuing operations was TWD 0.5714 compared to TWD 0.219 a year ago. Diluted earnings per share from continuing operations was TWD 0.5714 compared to TWD 0.219 a year ago.
For the nine months, sales was TWD 525.13 million compared to TWD 535.79 million a year ago. Net income was TWD 31.86 million compared to TWD 17.38 million a year ago. Basic earnings per share from continuing operations was TWD 0.6286 compared to TWD 0.3429 a year ago. Diluted earnings per share from continuing operations was TWD 0.6286 compared to TWD 0.3429 a year ago.